← All patents

US20100172962A1

Therapeutic targeting of interleukins using sirna in neutral liposomes

University of Texas System

Abstract

The present invention relates to the fields of molecular biology and drug delivery. In certain embodiments, the present invention provides compositions that include an siRNA targeted to an interleukin and a neutral lipid, and methods of treating a human subject with cancer involving administering …

University
University of Texas System
Assignee
The Board Of Regents Of The University Of Texas System
Inventor
William M. Merritt
Priority date
March 02, 2007
Filing date
February 29, 2008
Publication date
July 08, 2010
Language
en
Metadata fetched
August 29, 2026 00:19